icon-folder.gif   Conference Reports for NATAP  
 
  Digestive Disease Week
May 18-21, 2024
Washington, D.C.
Back grey_arrow_rt.gif
 
 
 
SGLT2I REDUCES THE RISK OF DEVELOPING HCC IN PATIENTS WITH CO-EXISTING HEPATITIS C INFECTION AND TYPE 2 DIABETES: A GLOBAL MULTICENTER PROPENSITY-MATCHED STUDY
 
 
 

0521241

0521242

0521243

0521244

0521245